First-line use of calcipotriene/betamethasone dipropionate combination products for the treatment of plaque psoriasis is associated with lower health care utilization and cost
May 1, 2013, 00:00
10.1016/j.jval.2013.03.561
https://www.valueinhealthjournal.com/article/S1098-3015(13)00632-3/fulltext
Title :
First-line use of calcipotriene/betamethasone dipropionate combination products for the treatment of plaque psoriasis is associated with lower health care utilization and cost
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00632-3&doi=10.1016/j.jval.2013.03.561
First page :
A117
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
105